Original language | English |
---|---|
Pages (from-to) | 122-134 |
Number of pages | 13 |
Journal | Journal of Pharmacology and Experimental Therapeutics |
Volume | 373 |
Issue number | 1 |
DOIs | |
Publication status | Published (VoR) - 1 Apr 2020 |
CSTI-300 (SMP-100); a novel 5-HT3 receptor partial agonist with potential to treat patients with irritable bowel syndrome or carcinoid syndromes
Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo, Nicholas M. Barnes*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
10
Citations
(SciVal)